Tc 99m dianexin

Drug Profile

Tc 99m dianexin

Alternative Names: 99m-Tc-HYNIC annexin V; 99m-Tc-HYNIC dianexin; 99m-Tc-HYNIC-annexin A5; 99mTc-4,5-bis(thioacetamido)pentanoyl-annexin-V; 99mTc-BTAP-annexin-V; Apomate; Tc 99m annexin-V; Tc 99m-HYNIC annexin V; Technetium Tc 99m BTAP-annexin-V; Technetium Tc 99m HYNIC annexin V

Latest Information Update: 14 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Stanford University
  • Class Calcium binding proteins; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Tissue degeneration
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Tissue degeneration

Most Recent Events

  • 07 Nov 2006 AnorMED has been acquired by Genzyme Corporation
  • 06 Jul 2004 North American Sicentific presented observations from an ongoing European clinical trial with Tc 99m dianexin in patients with non-small lung cancer
  • 14 Oct 2003 North American Scientific announced preliminary data from an ongoing European study with Tc 99m dianexin
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top